PDL BioPharma (PDLI)

As we have operations outside of the United States, our financial results could be affected by changes in foreign currency exchange rates or weak economic conditions in the foreign markets in which we operate. To date, our foreign
operations have not been significant to our results of operations and financial condition; therefore, our current foreign currency risk is considered minimal.

As we have operations outside of the United States, our financial results could be affected by changes in foreign currency exchange rates or weak economic conditions in
the foreign markets in which we operate. To date, our foreign operations have not been significant to our results of operations and financial condition; therefore, our current foreign currency risk is considered minimal.

As we
have operations outside of the United States, our financial results could be
affected by changes in foreign currency exchange rates or weak economic
conditions in the foreign markets in which we operate. To date, our foreign
operations have not been significant to our results of operations and financial
condition; therefore, our current foreign currency risk is minimal.